Astrid Zimmermann

Company: Merck KGaA

Job title: Director - Oncology Research Unit

Seminars:

ATR & ATM Mode of Action & Therapeutic Potential 12:00 pm

• Establishing potential therapeutic and toxicity synergies of DDR combination therapies • A priori determination of potential toxicity though biological rational of combination choice to streamline discovery • Delivering optimal potency of novel molecules through optimized chemistry for combinationRead more

day: Day Two Track A